Health Care

4447 posts
The Market Online Video

Listen: From the Wire – Paradigm Biopharma CEO and Founder Paul Rennie

From The Wire: Senior markets reporter Jonathon Davidson sat down with Paradigm Biopharmaceuticals chief executive officer…
Lung imaging concept

Biotech lung imaging darling 4DX Medical back at $2.20/sh on Miami U contract

4DX Medical has seen its price jump back to $2.20/sh, as its next-gen lung imaging scan…
Chuffed bloke

Race Oncology’s placement-at-a-premium rewarded as shares jump +8%

Race Oncology has completed its recent A$3.2M placement – something that shareholders on the HotCopper forums…

Effective as an IV drug, a gel, and now an inhaler – Recce’s R327 can’t stop winning

Recce flagship antibacertial and anti-infective drug R327 has in a model that shows the drug could…
In vitro fertilisation

Monash IVF soars to 85cps as company rejects takeover offer despite -33% YTD returns

Monash IVF Group has soared +40% on Monday morning as the company rejected a non-binding takeover…
Prostate cancer examination discussion concept

Orthocell pops on nerve healing successes in prostate surgery patients

Orthocell has seen its share price jump on Thursday as the company unveils its latest early-stage…
Biotech chart concept

AFT Pharmaceuticals jumps +10% on $115M interim FY26 record revenue

AFT Pharmaceuticals has seen its price jump +10% just shy of $3/sh on Thursday morning as…
European Medicine Agency headquarters

Prescient Therapeutics jumps +15% on EU regulator interest in PTX-100

Prescient Therapeutics has jumped +15% after EU drug regulator European Medicines Agency awarded orphan drug designation.
CSL information on the logo of the office facade.

CSL to pour $2.3 billion into US investments in attempt to dodge Trump’s tariffs

CSL Ltd will be wielding as much as $2.3 billion as a weapon against Trump's U.S.…
Image of t-cells

Race Oncology launches fresh myeloid leukemia and lung cancer trials with RC220

Race Oncology has sought to expand the total addressable markets it can reach with its cancer…